Signaling via MEK/ERK and AKT/PI3K are linked to RhoA kinase activity and vascular smooth muscle cell (vSMC) contractility in the periphery, but largely unexplored in the cancer vasculature (Alexander and Owens, 2012; Lacolley et al, 2012). Here, MAP2K7 is linked to cancer.